Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy

Jason Gillman, Patrick Janulis, Roy Gulick, Carole L. Wallis, Baiba Berzins, Roger Bedimo, Kimberly Smith, Michael Aboud, Babafemi Taiwo

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences